跳至主要内容
临床试验/CTRI/2023/07/054879
CTRI/2023/07/054879尚未招募1 期

Effect of amalaki (Emblica officinalis Gaertn.) swarasa bhavita haridra (Curcuma longa Linn.) churna in patients with diabetic dyslipidemia. - NI

Ashna Noushad0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Type 2 diabetes mellitus with :
  • a) FBS more than 110mg/dl and less than 200 mg/dl.
  • b) PPBS greater than 140 mg/dl and less than 240 mg/dl.
  • c) HbA1C in range of 6.5 to 8.
  • 2) LDL in the range 130 mg/dl and above.
  • 3) Individuals ready to follow all procedures.

排除标准

  • 1) Individuals with known history of cardiac pathology, Chronic kidney disease, liver pathologies and hematological disorders.
  • 2) Individuals with known history of any other endocrinological disease like hypothyroidism, aldosteronism etc.
  • 3) Pregnant and lactating females.
  • 4) Participants who are already administering medication for dyslipidemia and diabetes.

研究者

发起方
Ashna Noushad

相似试验